Antón
Ambroa Abalo
Instituto de Salud Carlos III
Madrid, EspañaPublicacións en colaboración con investigadores/as de Instituto de Salud Carlos III (3)
2022
-
Adaptation of clinical isolates of Klebsiella pneumoniae to the combination of niclosamide with the efflux pump inhibitor phenyl-arginine-β-naphthylamide (PaβN): co-resistance to antimicrobials
The Journal of antimicrobial chemotherapy, Vol. 77, Núm. 5, pp. 1272-1281
-
Genomic Analysis of Molecular Bacterial Mechanisms of Resistance to Phage Infection
Frontiers in Microbiology, Vol. 12
-
The role of PemIK (PemK/PemI) type II TA system from Klebsiella pneumoniae clinical strains in lytic phage infection
Scientific Reports, Vol. 12, Núm. 1